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Abstract: Aim: To study existential distress or demoralization expressed as meaninglessness and helplessness in opioid de-
pendent patients. 
Method: Comparison of existential distress between opioid dependent patients (n=131), patients with advanced cancer 
(n=100) and a community based sample without severe psychiatric or somatic disorders (n=190) as measured with the De-
moralization Scale. 
Results: Community controls without somatic or psychiatric disorders have significantly lower scores on all Demoralization 
Subscales. Opioid dependent patients are strikingly more demoralized than patients with cancer. 
Conclusion: Opioid dependent patients suffer from severe existential distress (meaninglessness, helplessness) which can ex-
plain the high prevalence of suicide in this group. 
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INTRODUCTION 
 Addiction is more and more considered to be a chronic 
brain disease with a destructive lifestyle in which there is often 
loss of the meaning and purpose of life [1]. These two nega-
tive psychological aspects of addiction fit well in the concept 
of demoralization. As stated by Jerome Frank [2] demoraliza-
tion can result from persistent failure to cope with internally or 
externally induced stresses that the person and those close to 
him expect to handle. It is characterized by feelings of impo-
tence, isolation and despair. The person’s self-esteem is dam-
aged and he feels rejected by others. Alienation may contrib-
ute to a sense of meaninglessness of life. Patients seldom ask 
for help because of an existing disease only. They seek help 
because of the accompanying demoralization caused by their 
inability to solve problems [3]. This makes the construct of 
demoralization important in modern medicine, including ad-
diction medicine. 
 Demoralization comes up if persons are confronted with 
their inability to handle problems and covers a broad spectrum 
with disheartenment on the one and despair on the other end. 
Disheartenment is most characteristic of this mental state, but 
next to it are feelings of shame, anger, anxiety and alienation 
[4]. The phenomenology of demoralization in the medically ill 
is characterised by non-specific dysphoria, disheartenment, 
loss of confidence and development of subjective incompe-
tence, loss of meaning, hopelessness and helplessness, social 
disconnectedness and the desire to die. 
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 Demoralization is a chronic state of mind distinct from 
acute distress, failure to cope, depression and general uncer-
tainty about the future and can be regarded best as a general 
descriptor of chronic psychological distress. In describing de-
moralization this way it is synonymous with suffering or exis-
tential distress. This is in line with the original description of 
the concept by Jerome Frank. 
 Existential distress or demoralization is under investigated 
in opioid-dependent patients in comparison with other patient 
groups. In the care of patients with cancer and other advanced 
diseases, insight into existential distress has proved crucial to 
optimizing clinical response [5]. Helplessness and meaning-
lessness – expressions of existential distress – are important 
predictors for suicide [6] as are substance related disorders [7]. 
 Existential distress can be measured by a self report ques-
tionnaire that comprises loss of meaning and purpose, dyspho-
ria, disheartenment, helplessness and sense of failure r and 
captures demoralization reliably and validly [4]. 
 Addicted patients frequently provoke a multiplicity of feel-
ings, thoughts and reactions in health care providers because 
of their complex interactions during treatment or disease man-
agement [8, 9]. The countertransference reactions on the com-
plex behavior of addicted patients including their expression 
of existential distress can distance the clinician from the pa-
tient, with potential abandonment, which can augment the risk 
of suicide. Taking addiction as a disease, people afflicted by it 
are ill and should be treated as patients. In this treatment, more 
attention should be given to chronic existential distress as one 
of the potential sources of negative countertransference reac-
tions. 
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 The aim of this study is to explore chronic existential stress 
or demoralization in opioid dependent patients in long term 
methadone maintenance treatment. As far as we know, there 
are no comparative studies examining demoralization in sub-
stance dependent patients. We sought to examine this in 
opioid dependent patients, and to compare their demoraliza-
tion with patients with advanced cancer and a group of com-
munity-based subjects without serious somatic or psychiatric 
disorders. 
METHOD 
Participants 
 The opioid-dependent subjects were from a Methadone 
Maintenance Treatment (MMT) unit in the Netherlands taking 
part in a comprehensive study of psychiatric co-morbidity. 
Criteria for inclusion were MMT and willingness to provide 
informed consent. Patients unable to speech Dutch were ex-
cluded. Recruitment was from March to June 2006. 
 The study was approved by the Dutch ‘Ethical Assessment 
Committee for Experimental Investigations on People’. 
 The consecutive series of patients with advanced cancer 
attended either the Pain and Palliative Care or Psycho-
Oncology Clinics at the Peter MacCallum Cancer Institute 
(n=63) and the Psycho-oncology clinic or Caritas Christi Hos-
pice ward at St. Vincent’s Hospital (n=37) in Melbourne, Aus-
tralia. Exclusion criteria were: confusion, as defined by a Mini 
Mental Sate Examination of < 24; too unwell or frail; inability 
to read English; and psychosis or intellectual handicap. The 
institutional ethics committee gave approval for the study. 
 The community-based subjects were recruited by means of 
‘Snowball Sampling’ [3] in the social network of collaborators 
of the research institute NISPA. The potential participants 
received a ‘participant’s letter’ describing the purpose and 
significance of the project. Exclusion criteria were current 
treatment for somatic or psychiatric disorders. Two hundred 
and five questionnaires were sent, with a response rate of 
92.7%. 
Instrument 
 The Demoralization Scale [4]
 
(DS) is a self report ques-
tionnaire consisting of 24 statements (for instance ‘I no longer 
feel emotionally in control’) that should be answered on a five 
point Likert scale ranging from ‘never’ to ‘all the time’. The 
DS has five subscales describing (1) loss of meaning and pur-
pose, (2) dysphoria, (3) disheartenment, (4) helplessness and 
(5) sense of failure. The English version of the DS showed 
good reliability and validity. The subscales demonstrate satis-
factory internal coherence, yet sufficient differentiation from 
one other. Convergent validity was shown between the DS and 
other measures for existential distress, hopelessness, depres-
sion and a desire to die. The DS was able to differentiate a 
subset of patients who are demoralized and yet not clinically 
depressed. 
 Three translators independently translated the DS into 
Dutch. These were compared with each other to reach consen-
sus about item translation. The resultant consensus version 
was back-translated into English by a fourth, bilingual psy-
chologist. Differences between original and back-translated 
items were reviewed by the scale’s originator (DWK) and 
adjusted until the original meaning had been preserved. 
 The psychometric properties of the Dutch version were 
comparable with the English version [10] in the community 
based sample as well as in the opioid dependent group of pa-
tients. The Dutch version also pointed at an overlap between 
demoralization and acute distress, failure to cope, depression 
and general uncertainty about the future, but the extent of the 
overlap was such that demoralization should be regarded as a 
construct distinct from these other psychological constructs. 
Statistical Analysis 
 All quantitative data were entered and analyzed using 
SPSS (SPSS, Inc., Chicago, IL). To test for differences be-
tween the cohorts on the five subscales and the total score of 
the DS, ANOVAs with post hoc comparisons for observed 
means (Bonferroni) were performed. 
RESULTS 
 Socio-demographic characteristics of the three cohorts and 
five dimensions of the Demoralization Scale are shown in 
Table 1. It is clear that the three populations differ with respect 
to age and gender. The community group without somatic or 
psychiatric disorders has significantly lower scores on all de-
moralization subscales, pointing at the level of existential dis-
tress in the two cohorts of patients. Opioid-dependent patients 
are noteworthy for higher scores on all subscales of the DS 
than cancer patients. 
DISCUSSION 
 As far as we know, this is the first study that reports on the 
level of existential distress as measured with the Demoraliza-
tion Scale in opioid dependent patients. As expected, the two 
clinical cohorts showed significantly higher scores on all sub-
scales of the Demoralization Scale. Surprisingly, the opioid 
dependent patients proved to be significantly more demoral-
ized than patients with advanced cancer. 
 One limitation of our study is that the design does not al-
low us to control for differences in the populations other than 
the aspects of demoralization. Any conclusions about these 
differences can only be tentative, but age, gender, the longer 
duration of illness and the frequently noticed lack of a social 
network in the opioid-dependent patients should be taken into 
account as confounders. 
 The differences in demoralization found in this study could 
be accounted for by cross-cultural differences in the popula-
tions studied. Although he psychometric evaluation of the 
Dutch version of the Demoralization Scale showed close re-
semblance with the original version cross-cultural differences 
could not be ruled out. Therefore further research is needed in 
homogenous populations such as opioid dependent patients in 
methadone maintenance treatment in different countries. Nev-
ertheless, the size of differences is such that in our opinion 
conclusions should be drawn concerning the clinical impor-
tance of the degree of demoralization in the opioid dependent 
population in methadone maintenance treatment. Another 
limitation is that other psychological constructs or psychiatric 
disorders were not measured in the three groups in the same 
way, which made it difficult to explore the overlap and dis-
tinctions in detail. If demoralization is taken as a descriptor of 
general chronic distress the high level of distress found in 
opioid dependent patients is an important point of attention in 
the clinical encounter. 
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 Addiction is more and more regarded as a chronic brain 
disease with a complex biopsychosocial background including 
genetic vulnerability, early traumatisation, personality pathol-
ogy and societal influences. In this complex interplay between 
biological, psychological and societal aspects of dependence 
and chronic states of mind the neurobiological aspects of a 
chronic demoralization and the association with the changes in 
the functions of the addicted brain are still to be elucidated. 
 In the consulting room therapists are confronted with de-
moralized addicted patients. The plight of opioid-dependent 
patients and their potential to become disheartened, develop 
meaninglessness, helplessness, dysphoria and a sense of fail-
ure is noteworthy – in short, they risk profound demoraliza-
tion. Important consequences about the degree of demoraliza-
tion found in this study include its possible negative impact on 
patients in their efforts to achieve a healthier lifestyle. But it 
also influences their relationships with professionals in addic-
tion treatment programs, through transfer of their feelings of 
demoralization onto their therapists. Therapists dealing with 
severely demoralized opioid-dependent patients need to un-
derstand how their counter-transference impacts upon the 
working alliance and strive for the same sensitivity expected 
with other life threatening diseases. Addicted patients are not 
always easy to deal with because of their complex behavior in 
interpersonal encounters and they arouse different and often 
confusing feelings in therapists [8]. Demoralization adds to 
these complexity and can result in feelings of detachment or 
withdrawal in therapists. Suicide may be a tragic outcome if 
the existential distress or demoralization is not recognized and 
left untreated because of these kind of feelings in therapists. 
REFERENCES 
[1] Volkow ND, Li TK. Drugs and alcohol: treating and preventing 
abuse, addiction and their medical consequences. Pharmacol Ther 
2005; 108(1): 3-17. 
[2] Frank JD. Psychotherapy, the restoration of morale. Am J Psychiatry 
1974; 131: 271-4. 
[3] Stoffer R. Demoralization and the failed mission. In the footsteps of 
Jerome D Frank. J Psychother 2001; 27: 366-79. 
[4] Kissane DW, Wein S, Love A, Lee XQ, Kee PL, Clarke DM. The 
Demoralization scale: a report of its development and preliminary 
validation. J Palliati Care 2004; 20(4): 269-76. 
[5] Kissane DW, Clarke DM, Street AF. Demoralization syndrome - a 
relevant psychiatric diagnosis for palliative care. J Palliat Care 2001; 
17: 12-21. 
[6] Kuo WH, Gallo JJ, Eaton WW. Hopelessness, depression, substance 
disorder, and suicidality--a 13-year community-based study. Soc Psy-
chiatry Psychiatr Epidemiol 2004; 39(6): 497-501. 
[7] Tondo L, Baldessarini RJ, Hennen J, Minnai GP, Salis P, Scamonatti 
L. Suicide attempts in major affective disorder patients with comor-
bid substance use disorders. J Clin Psychiatry 1999; 60(Suppl 2) :63-
9. 
[8] Imhof JE. Overcoming countertransference and other attiduninal 
barriers in the treatment of substance abuse. In: Washton AM, Ed. 
Psychotherapy and substance abuse: A Practitioner's Handbook. The 
Guilford Press: New York 1995. 
[9] Forrest GG. Countertransference in chemical dependence counseling. 
The Haworth Press: New York 2002. 
[10] Geesink RJ. Demoralization in a normal population: validation of the 
Demoralization scale. Master thesis, Radboud University Nijmegen, 
2006. 
 
 
Received: May 22, 2008 Revised: July 22, 2008 Accepted: July 25, 2008 
 
© Jong et al.; Licensee Bentham Open. 
 
This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-
nc/3.0/ <http://creativecommons.org/licenses/by-nc/3.0/>) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided 
the work is properly cited. 
 
Table 1. Means (SD) of Total Score and Subscales of the Demoralization Scale Compared Between a Community-Based Normative 
Sample and Cohorts of Opioid-Dependent and Cancer Patients Using Analysis of Variance 
 
Socio-Demographic Features and  
Subscale Scores of the Demoralization 
Scale (DS) 
Community-
Based (n=190) 
a 
Opioid-Dependent 
(n=131) 
b 
Cancer  
(n=100) 
c 
F  p 
Significant Posthoc  
Comparisions  
(Bonferroni) 
Age, mean (SD) in years 37.3 (13.6) 41.7 (7.4) 59.3 (12.2) 
Gender 
 male  66 (35%) 111 (85%) 47 (47%) 
 female 124 (65%)  20 (15%) 53 (53%) 
Duration of illness, mean (SD), in years not relevant 
15.4 (8.2)1 
12.5 (7.6)2 
2.7 (4.1) 
 
Loss of meaning and purpose 2.3 (2.7) 7.2 (5.0)  5.1 (4.8) 58.20  < .001 a-b,a-c,b-c 
Dysphoria 6.2 (3.0) 9.7 (4.2) 6.4 (4.5) 36.25 < .001 a-b,b-c, 
Disheartenment 5.7 (4.4) 11.9 (5.3) 8.9 (5.8) 84.76 < .001 a-b,a-c,b-c 
Helplessness 2.5 (2.2)  7.3 (3.4) 5.3 (4.1) 55.84 < .001 a-b,a-c,b-c 
Sense of failure 4.4 (2.1) 6.6 (3.1) 5.2 (2.9) 27.51 < .001 a-b,a-c,b-c 
Total DS score 21.1 (12.6) 43.2 (17.1)  30.8 (17.7) 77.65 < .001 a-b,a-c,b-c 
1Heroine use in years 2 Methadone use in years. 
